Table 2. TCTN2 frequency in CRC using an anti-TCTN2 mAb.

Clinical Parameter	Status/Score	Total Positive (%)	Medium-Strong Positive (%)
Histology	adenocarcinoma	134/141 (95)	34/141 (24)
	mucinous	19/22 (86)	1/22 (4)
Stage	1	27/27 (100)	8/27 (30)
	2	43/47 (91)	10/47 (21)
	3	52/53 (98)	13/53 (24)
	4	27/32 (84)	4/32 (12)
pT	1	10/10 (100)	1/10 (10)
	2	30/31 (97)	8/31 (26)
	3	90/95 (95)	24/95 (25)
	4	24/28 (86)	2/28 (7)
pN	0	74/79 (94)	19/79 (24)
	1	45/47 (96)	11/47 (23)
	2	29/32 (91)	5/32 (16)
Grading	1&2	112/119 (94)	30/119 (25)
	3	41/44 (93)	5/44 (11)
Metastasis	No	94/99 (95)	25/99 (25)
	Yes	62/67 (92)	10/67 (15)
Vascular Invasion	No	41/44 (93)	9/44 (20)
	Yes	111/118 (94)	26/118 (22)
Sex	female	81/87 (93)	22/87 (25)
	male	75/79 (95)	13/79 (16)

Fisher's exact test P value < 0.05 is represented by asterisk ^*